BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 33583248)

  • 1. Psychometric Properties of a DSM-5-Based Screening Tool for Women's Perceptions of Premenstrual Symptoms.
    Richards MA; Oinonen KA
    Psychol Rep; 2022 Apr; 125(2):1186-1217. PubMed ID: 33583248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A symptom diary to assess severe premenstrual syndrome and premenstrual dysphoric disorder.
    Janda C; Kues JN; Andersson G; Kleinstäuber M; Weise C
    Women Health; 2017 Aug; 57(7):837-854. PubMed ID: 27355449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward the Reliable Diagnosis of DSM-5 Premenstrual Dysphoric Disorder: The Carolina Premenstrual Assessment Scoring System (C-PASS).
    Eisenlohr-Moul TA; Girdler SS; Schmalenberger KM; Dawson DN; Surana P; Johnson JL; Rubinow DR
    Am J Psychiatry; 2017 Jan; 174(1):51-59. PubMed ID: 27523500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survey of premenstrual symptom severity and impairment in Korean adolescents: premenstrual dysphoric disorder, subthreshold premenstrual dysphoric disorder and premenstrual syndrome.
    Yang J; Joe SH; Lee MS; Kim SH; Jung IK
    Asia Pac Psychiatry; 2014 Jun; 6(2):135-44. PubMed ID: 23857722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How to measure the impact of premenstrual symptoms? Development and validation of the German PMS-Impact Questionnaire.
    Kues JN; Janda C; Kleinstäuber M; Weise C
    Women Health; 2016 Oct; 56(7):807-26. PubMed ID: 26624615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a screening instrument to assess premenstrual dysphoric disorder as conceptualized in DSM-5.
    Aperribai L; Alonso-Arbiol I; Balluerka N; Claes L
    J Psychosom Res; 2016 Sep; 88():15-20. PubMed ID: 27521647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Premenstrual dysphoric disorder in Arab women: Validation and cultural adaptation of the Arabic version of the premenstrual screening tool.
    Mahfoud Z; Emam R; Anchassi D; Omran S; Alhaj N; Al-Abdulla S; El-Amin A; Shehata M; Aly S; Al Emadi N; Al-Meer F; Al-Amin H
    Women Health; 2019 Jul; 59(6):631-645. PubMed ID: 30475684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of premenstrual impairment among women undergoing prospective assessment for premenstrual dysphoric disorder: a cycle-level analysis.
    Schmalenberger KM; Eisenlohr-Moul TA; Surana P; Rubinow DR; Girdler SS
    Psychol Med; 2017 Jul; 47(9):1585-1596. PubMed ID: 28193300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Daily symptom ratings for studying premenstrual dysphoric disorder: A review.
    Bosman RC; Jung SE; Miloserdov K; Schoevers RA; aan het Rot M
    J Affect Disord; 2016 Jan; 189():43-53. PubMed ID: 26406968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methods for coping with premenstrual change: Development and validation of the German Premenstrual Change Coping Inventory.
    Kaiser G; Kues JN; Kleinstäuber M; Andersson G; Weise C
    Women Health; 2018 Oct; 58(9):1062-1079. PubMed ID: 29111950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clusters of premenstrual symptoms in women with PMDD: Appearance, stability and association with impairment.
    Kaiser G; Janda C; Kleinstäuber M; Weise C
    J Psychosom Res; 2018 Dec; 115():38-43. PubMed ID: 30470315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [SIPS--screening instrument for premenstrual symptoms. The German version of Premenstrual Symptoms Screening Tool to assess clinically relevant disturbances].
    Bentz D; Steiner M; Meinlschmidt G
    Nervenarzt; 2012 Jan; 83(1):33-9. PubMed ID: 21221519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Daily Record of Severity of Problems (DRSP): reliability and validity.
    Endicott J; Nee J; Harrison W
    Arch Womens Ment Health; 2006 Jan; 9(1):41-9. PubMed ID: 16172836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emotional regulation difficulties and premenstrual symptoms among Israeli students.
    Reuveni I; Dan R; Segman R; Evron R; Laufer S; Goelman G; Bonne O; Canetti L
    Arch Womens Ment Health; 2016 Dec; 19(6):1063-1070. PubMed ID: 27538401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insomnia, Inattention and Fatigue Symptoms of Women with Premenstrual Dysphoric Disorder.
    Lin PC; Ko CH; Lin YJ; Yen JY
    Int J Environ Res Public Health; 2021 Jun; 18(12):. PubMed ID: 34201084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Premenstrual disorders among young Turkish women: According to DSM-IV and DSM-V criteria using the premenstrual symptoms screening tool.
    Daşıkan Z
    Perspect Psychiatr Care; 2021 Apr; 57(2):481-487. PubMed ID: 33111372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Premenstrual Dysphoric Disorder and Eating Behaviors Among Nursing Students: A Cross-Sectional Study.
    Çoban ÖG; Karakaya D; Önder A; İşleyen Z; Adanır AS
    J Pediatr Adolesc Gynecol; 2021 Apr; 34(2):203-208. PubMed ID: 33271293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Women's experiences of receiving a diagnosis of premenstrual dysphoric disorder: a qualitative investigation.
    Osborn E; Wittkowski A; Brooks J; Briggs PE; O'Brien PMS
    BMC Womens Health; 2020 Oct; 20(1):242. PubMed ID: 33115437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of premenstrual symptoms: validation of the Italian version of the Premenstrual Symptoms Screening Tool.
    Pacitti F; Iorio C; Riccobono G; Iannitelli A; Pompili A
    Riv Psichiatr; 2021; 56(5):246-253. PubMed ID: 34663991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emotion regulation in women with premenstrual dysphoric disorder.
    Petersen N; London ED; Liang L; Ghahremani DG; Gerards R; Goldman L; Rapkin AJ
    Arch Womens Ment Health; 2016 Oct; 19(5):891-8. PubMed ID: 27155663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.